Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)

Clinical trial NCT05036005 · UNKNOWN

Trial details

NCT number: NCT05036005
Sponsor: Institut fuer Frauengesundheit
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Breast Cancer Breast Neoplasms Breast Cancer Female HER2-positive Breast Cancer

Start date: 2021-07-11
Primary completion: 2023-04-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.